Zhoulang Wang

1.9k total citations
6 papers, 264 citations indexed

About

Zhoulang Wang is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Zhoulang Wang has authored 6 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Molecular Biology and 1 paper in Neurology. Recurrent topics in Zhoulang Wang's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Andrographolide Research and Applications (1 paper). Zhoulang Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Andrographolide Research and Applications (1 paper). Zhoulang Wang collaborates with scholars based in China, Macao and United States. Zhoulang Wang's co-authors include Zifeng Yang, Haiming Jiang, Qinhai Ma, Yuqi Xie, Jicheng Huang, Jun Dai, Runfeng Li, Yongxia Shi, Chufang Li and Kui Zheng and has published in prestigious journals such as Journal of Ethnopharmacology, Pharmacological Research and Phytomedicine.

In The Last Decade

Zhoulang Wang

6 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhoulang Wang China	6	86	82	61	61	45	6	264
Yuqi Xie China	4	88 1.0×	70 0.9×	56 0.9×	59 1.0×	47 1.0×	4	230
Maren Bormann Germany	9	79 0.9×	72 0.9×	98 1.6×	73 1.2×	43 1.0×	12	338
Lukas van de Sand Germany	7	79 0.9×	58 0.7×	98 1.6×	73 1.2×	41 0.9×	14	291
Wen‐Ho Chuo Taiwan	10	106 1.2×	97 1.2×	66 1.1×	77 1.3×	29 0.6×	15	447
Anamika Gupta India	10	68 0.8×	87 1.1×	32 0.5×	28 0.5×	28 0.6×	23	295
Lijuan Zeng China	4	86 1.0×	71 0.9×	82 1.3×	82 1.3×	67 1.5×	5	332
Yea–In Park South Korea	8	66 0.8×	98 1.2×	36 0.6×	39 0.6×	34 0.8×	22	369
Yu Hao China	11	43 0.5×	158 1.9×	67 1.1×	35 0.6×	66 1.5×	29	418
Chia‐Shin Yang Taiwan	8	132 1.5×	102 1.2×	41 0.7×	33 0.5×	58 1.3×	20	332
Astrid Feinisa Khairani Indonesia	9	39 0.5×	67 0.8×	38 0.6×	68 1.1×	17 0.4×	36	303

Countries citing papers authored by Zhoulang Wang

Since Specialization

Citations

This map shows the geographic impact of Zhoulang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhoulang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhoulang Wang more than expected).

Fields of papers citing papers by Zhoulang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhoulang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhoulang Wang. The network helps show where Zhoulang Wang may publish in the future.

Co-authorship network of co-authors of Zhoulang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhoulang Wang. A scholar is included among the top collaborators of Zhoulang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhoulang Wang. Zhoulang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ma, Qinhai, Yuqi Xie, Zhoulang Wang, et al.. (2021). Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. Journal of Ethnopharmacology. 279. 114367–114367. 26 indexed citations

2.

Ma, Qinhai, Zhoulang Wang, Ruihan Chen, et al.. (2021). Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action. Phytomedicine. 95. 153874–153874. 14 indexed citations

3.

Ti, Huihui, Zhitong Mai, Zhoulang Wang, et al.. (2021). Bisabolane-type sesquiterpenoids fromCurcuma longaL. exert anti-influenza and anti-inflammatory activities through NF-κB/MAPK and RIG-1/STAT1/2 signaling pathways. Food & Function. 12(15). 6697–6711. 25 indexed citations

4.

Chen, Xiaofei, Zhoulang Wang, Zeqiang Xie, et al.. (2020). A Boron Dipyrromethene‐Based Fluorescence ‘OFF‐ON’ Probe for Sensitive and Selective Detection of Palladium(II) Ions and Its Application in Live Cell Imaging. Chemistry - An Asian Journal. 15(23). 4104–4112. 17 indexed citations

5.

Ma, Qinhai, Runfeng Li, Weiqi Pan, et al.. (2020). Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Phytomedicine. 78. 153296–153296. 84 indexed citations

6.

Ma, Qinhai, Weiqi Pan, Runfeng Li, et al.. (2020). Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway. Pharmacological Research. 158. 104850–104850. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact